ARV-825 - ≥97% , CAS No.1818885-28-7

CAS: 1818885-28-7 Cat. No.: A413965 Formule: C46H47ClN8O9S Poids moléculaire: 923.43
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ ≥97%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
Application
PROTAC
★
Taille
Allemagne (EU)
USA*
Prix
Qté
1mg
A413965-1mg
—
2 En stock

35,49€

53,71€
Enregistrer 18,22 € (33.93%)
5mg
A413965-5mg
—
2 En stock

130,94€

196,89€
Enregistrer 65,95 € (33.49%)
10mg
A413965-10mg
—
2 En stock

171,73€

257,63€
Enregistrer 85,91 € (33.34%)
25mg
A413965-25mg
—
1 En stock

268,91€

403,41€
Enregistrer 134,50 € (33.34%)
50mg
A413965-50mg
—
1 En stock

423,37€

635,10€
Enregistrer 211,73 € (33.34%)
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Information

ARV-825 is a BRD4 Inhibitor that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degradation of BRD4 and sustained down-regulation of MYC.


Targets

BRD4 BD2 (Cell-free assay); BRD4 BD1 (Cell-free assay) 28 nM(Kd); 90 nM(Kd)


In vitro

Compared with the BRD4 inhibitors, ARV-825 treatment results in a strikingly more pronounced effect on the levels of c-MYC, and downstream cell proliferation and apoptosis induction in BL (Burkitt’s Lymphoma) cell lines. The IC50s of ARV-825 for all tested cell lines and primary AML cells at 72 hours are in the low nanomolar range (2-50 nM). ARV-825 treatment reduces PIM1 levels and phosphorylation of CXCR4 in AML cells while overexpression of PIM1 or Myc reverses the phenomena.


In vivo

In a mouse model of human leukemia, the leukemia burdens are significantly lower in the ARV-825 treated mice as confirmed by luciferase imaging, flow cytometry, spleen size and survived longer compared to control mice.


Cell Research(from reference)

Cell lines:RS4;11 cells 

Concentrations:3, 10, 30 nM 

Incubation Time:3 h 

Spécifications

Spécifications et pureté
≥97%
Mécanismes biochimiques et physiologiques
ARV-825 is a BRD4 Inhibitor that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degradation of BRD4 and sustained down-regulation of MYC.
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
INHIBITOR
Pureté
≥97%
Noms et identifiants
Pubchem Sid
SMILES
CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)OCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C8=CC=C(C=C8)Cl)C
IUPAC Name
2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-[4-[2-[2-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]phenyl]acetamide
InChIKey
RWLOGRLTDKDANT-TYIYNAFKSA-N
InChI
1S/C46H47ClN8O9S/c1-26-27(2)65-46-39(26)41(29-7-9-30(47)10-8-29)50-35(42-53-52-28(3)54(42)46)25-38(57)49-31-11-13-32(14-12-31)64-24-23-63-22-21-62-20-19-61-18-17-48-34-6-4-5-33-40(34)45(60)55(44(33)59)36-15-16-37(56)51-43(36)58/h4-14,35-36,48H,15-25H2,1-3H3,(H,49,57)(H,51,56,58)/t35-,36?/m0/s1
Isomères SMILES
CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)OCCOCCOCCOCCNC5=CC=CC6=C5C(=O)N(C6=O)C7CCC(=O)NC7=O)C8=CC=C(C=C8)Cl)C
Poids moléculaire
923.43
Reaxys
29518940
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=29518940&ln=

Données avancées

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasseIsoindoles and derivatives
SubclassIsoindolines
Intermediate Tree Nodes Isoindolones
Direct ParentPhthalimides
Alternative Parents Alpha amino acids and derivatives  Thienodiazepines  Anilides  Isoindoles  N-arylamides  Phenol ethers  Phenoxy compounds  Piperidinediones  Secondary alkylarylamines  Alkyl aryl ethers  Chlorobenzenes  Delta lactams  1,4-diazepines  Aryl chlorides  N-substituted carboxylic acid imides  Vinylogous amides  Triazoles  Dicarboximides  Heteroaromatic compounds  Thiophenes  N-unsubstituted carboxylic acid imides  Secondary carboxylic acid amides  Ketimines  Dialkyl ethers  Propargyl-type 1,3-dipolar organic compounds  Azacyclic compounds  Organic oxides  Organochlorides  Carbonyl compounds  Hydrocarbon derivatives  Organopnictogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phthalimide - Thieno-para-diazepine - Alpha-amino acid or derivatives - Isoindole - Anilide - Piperidinedione - Phenoxy compound - Phenol ether - N-arylamide - Piperidinone - Secondary aliphatic/aromatic amine - Para-diazepine - Alkyl aryl ether - Halobenzene - Delta-lactam - Chlorobenzene - Aryl halide - Benzenoid - Monocyclic benzene moiety - Piperidine - Aryl chloride - Carboxylic acid imide, n-substituted - Azole - Heteroaromatic compound - Carboxylic acid imide - Vinylogous amide - Dicarboximide - 1,2,4-triazole - Carboxylic acid imide, n-unsubstituted - Thiophene - Secondary carboxylic acid amide - Lactam - Ketimine - Carboxamide group - Amino acid or derivatives - Secondary amine - Propargyl-type 1,3-dipolar organic compound - Carboxylic acid derivative - Azacycle - Dialkyl ether - Ether - Organic 1,3-dipolar compound - Hydrocarbon derivative - Carbonyl group - Organic oxygen compound - Organic nitrogen compound - Organic oxide - Organopnictogen compound - Organooxygen compound - Amine - Organonitrogen compound - Imine - Organochloride - Organohalogen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides.
External Descriptors Not available
Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
BRD4 Tchem Bromodomain-containing protein 4 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CRBN Tclin Protein cereblon (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RS4-11 (1012 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLM-13 (2241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Protein cereblon (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRBN Tclin Cereblon/Ikaros (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 4 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD2 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 2 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD3 Tchem Cereblon/Cullin-4A/Bromodomain-containing protein 3 (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Cereblon/Bromodomain-containing protein 4 (275 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 4 (105 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem von Hippel-Lindau disease tumor suppressor/Elongin-B/Elongin-C/Bromodomain-containing protein 4 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD2 Tchem von Hippel-Lindau disease tumor suppressor/Elongin-B/Elongin-C/Bromodomain-containing protein 2 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD3 Tchem von Hippel-Lindau disease tumor suppressor/Elongin-B/Elongin-C/Bromodomain-containing protein 3 (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cibles associées (non humaines)
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeDateArticle
E2422384E2422384Certificate of AnalysisFeb 26, 2024 A413965
E2422386E2422386Certificate of AnalysisFeb 26, 2024 A413965
E2422387E2422387Certificate of AnalysisFeb 26, 2024 A413965
E2422388E2422388Certificate of AnalysisFeb 26, 2024 A413965
E2422389E2422389Certificate of AnalysisFeb 26, 2024 A413965
E2422390E2422390Certificate of AnalysisFeb 26, 2024 A413965
E2422391E2422391Certificate of AnalysisFeb 26, 2024 A413965
E2422392E2422392Certificate of AnalysisFeb 26, 2024 A413965
E2422393E2422393Certificate of AnalysisFeb 26, 2024 A413965
E2422396E2422396Certificate of AnalysisFeb 26, 2024 A413965
Propriétés chimiques et physiques
SolubilitéSolubility (25°C) In vitro DMSO: 100 mg/mL (108.29 mM); Ethanol: 3 mg/mL (3.24 mM); Water: Insoluble;
Poids moléculaire923.4
XLogP34.800
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count14
Rotatable Bond Count19
Exact Mass922.288 Da
Monoisotopic Mass922.288 Da
Topological Polar Surface Area233.000 Ų
Heavy Atom Count65
Formal Charge0
Complexity1720.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sécurité et dangers (GHS)
Reaxys
29518940
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=29518940&ln=
FAQ et articles
Calculateurs de solution
Avis

Avis des clients

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.